Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ZYMERGEN INC.

(ZY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Zymergen : JPMorgan Starts Zymergen at Overweight With $40 Price Target

05/17/2021 | 08:23am EDT


© MT Newswires 2021
All news about ZYMERGEN INC.
04:57pKESSLER TOPAZ MELTZER & CHECK, LLP : Reminds Investors Of Deadline For Securitie..
PR
01:01pGLANCY PRONGAY & MURRAY LLP : Reminds Investors of Looming Deadline in the Class..
PR
09/10ZYMERGEN INC. (NASDAQ : ZY) LAWSUIT FILING DEADLINE: Bernstein Liebhard LLP Remi..
PR
09/07ZYMERGEN INC. CLASS ACTION ALERT : Wolf Haldenstein Adler Freeman & Herz LLP rem..
PR
09/06KESSLER TOPAZ MELTZER & CHECK, LLP : Reminds Investors of Securities Fraud Class..
PR
09/06ZYMERGEN : ROSEN, A LEADING LAW FIRM, Encourages Zymergen Inc. Investors to Secu..
PR
09/02Today on Wall Street: The last week of summer
09/02ANALYST RECOMMENDATIONS : AstraZeneca, Designer Brands, Homeserve, Rio Tinto, Tr..
09/01ZYMERGEN : ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Zymergen Inc. Investors Wi..
BU
09/01ZYMERGEN : UBS Downgrades Zymergen to Neutral Rating From Buy, Adjusts Price Tar..
MT
More news
Analyst Recommendations on ZYMERGEN INC.
More recommendations
Financials (USD)
Sales 2021 17,7 M - -
Net income 2021 -361 M - -
Net cash 2021 347 M - -
P/E ratio 2021 -3,51x
Yield 2021 -
Capitalization 1 420 M 1 420 M -
EV / Sales 2021 60,7x
EV / Sales 2022 40,6x
Nbr of Employees 758
Free-Float 91,1%
Chart ZYMERGEN INC.
Duration : Period :
Zymergen Inc. Technical Analysis Chart | ZY | US98985X1000 | MarketScreener
Technical analysis trends ZYMERGEN INC.
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Last Close Price 13,87 $
Average target price 10,40 $
Spread / Average Target -25,0%
EPS Revisions
Managers and Directors
Jay T. Flatley Chairman & Chief Executive Officer
Enakshi Singh Chief Financial Officer
Zachariah Serber Director & Chief Science Officer
Jed Dean Vice President-Operations & Engineering
Aaron Kimball Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
ZYMERGEN INC.0.00%1 408
PROCTER & GAMBLE COMPANY3.57%349 945
UNILEVER PLC-10.15%140 368
THE ESTÉE LAUDER COMPANIES INC.21.39%116 743
HINDUSTAN UNILEVER LIMITED13.68%88 335
COLGATE-PALMOLIVE COMPANY-10.57%64 503